CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Agenus Incorporation Company Snapshot
Agenus Incorporation operates within the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Agenus Incorporation with three other companies in this sector in the United States: Editas Medicine Inc (2018 sales of $31.94 million of which 100% was Pharmaceutical), Protalix Biotherapeutics Inc ($34.24 million of which 100% was Biotherapeutic Products), and Novavax, Inc. ($34.29 million of which 100% was Pharmaceutical Products).

Sales Analysis. During the year ended December of 2018, sales at Agenus Incorporation were $36.78 million. This is a decrease of 14.2% versus 2017, when the company's sales were $42.88 million.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Agenus Incorporation
  Stock Performance Chart for Agenus Incorporation
 
  Stock Data: Recent Stock Performance:
  Current Price (8/16/2019): 2.83
(Figures in U.S. Dollars)
1 Week 9.7%   13 Weeks 15.0%  
4 Weeks -4.1%   52 Weeks 69.5%  
 
Agenus Incorporation Key Data:
  Ticker: AGEN Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2018 Sales 36,783,551
(Year Ending Jan 2019).
Employees: 294
  Currency: U.S. Dollars Market Cap: 388,443,561
  Fiscal Yr Ends: December Shares Outstanding: 137,259,209
  Share Type: Common Closely Held Shares: 32,448,322
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.